Smith Salley Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.09M | Buy |
11,307
+205
| +2% | +$70.2K | 0.18% | 87 |
|
|
2026
Q1 | $3.91M | Buy |
11,102
+316
| +3% | +$113K | 0.2% | 89 |
|
|
2025
Q4 | $3.53M | Buy |
10,786
+30
| +0.3% | +$9.52K | 0.17% | 89 |
|
|
2025
Q3 | $3.04M | Buy |
10,756
+53
| +0.5% | +$15.4K | 0.16% | 98 |
|
|
2025
Q2 | $2.99M | Sell |
10,703
-100
| -0.9% | -$28.3K | 0.17% | 87 |
|
|
2025
Q1 | $3.37M | Sell |
10,803
-4,035
| -27% | -$1.19M | 0.22% | 76 |
|
|
2024
Q4 | $3.87M | Sell |
14,838
-10
| -0.1% | -$2.97K | 0.25% | 68 |
|
|
2024
Q3 | $4.78M | Buy |
14,848
+265
| +2% | +$86.7K | 0.31% | 59 |
|
|
2024
Q2 | $4.56M | Buy |
14,583
+71
| +0.5% | +$20.9K | 0.33% | 58 |
|
|
2024
Q1 | $4.13M | Sell |
14,512
-3,568
| -20% | -$1.04M | 0.32% | 59 |
|
|
2023
Q4 | $5.21M | Sell |
18,080
-480
| -3% | -$131K | 0.34% | 62 |
|
|
2023
Q3 | $4.99M | Sell |
18,560
-62
| -0.3% | -$15.5K | 0.37% | 60 |
|
|
2023
Q2 | $4.13M | Buy |
18,622
+4,196
| +29% | +$974K | 0.31% | 67 |
|
|
2023
Q1 | $3.49M | Buy |
14,426
+207
| +1% | +$50.8K | 0.28% | 72 |
|
|
2022
Q4 | $3.73M | Sell |
14,219
-3,207
| -18% | -$860K | 0.32% | 71 |
|
|
2022
Q3 | $3.93M | Buy |
17,426
+76
| +0.4% | +$18.4K | 0.37% | 69 |
|
|
2022
Q2 | $4.22M | Buy |
17,350
+680
| +4% | +$167K | 0.37% | 66 |
|
|
2022
Q1 | $4.03M | Buy |
16,670
+513
| +3% | +$118K | 0.3% | 74 |
|
|
2021
Q4 | $3.63M | Sell |
16,157
-462
| -3% | -$97.5K | 0.26% | 82 |
|
|
2021
Q3 | $3.54M | Buy |
16,619
+759
| +5% | +$175K | 0.28% | 76 |
|
|
2021
Q2 | $3.87M | Sell |
15,860
-2
| -0% | -$492 | 0.31% | 69 |
|
|
2021
Q1 | $3.95M | Buy |
15,862
+256
| +2% | +$61.1K | 0.35% | 65 |
|
|
2020
Q4 | $3.59M | Sell |
15,606
-61
| -0.4% | -$14.1K | 0.36% | 64 |
|
|
2020
Q3 | $3.98M | Buy |
15,667
+121
| +0.8% | +$30K | 0.48% | 58 |
|
|
2020
Q2 | $3.67M | Buy |
15,546
+636
| +4% | +$145K | 0.49% | 57 |
|
|
2020
Q1 | $3.02M | Sell |
14,910
-618
| -4% | -$135K | 0.5% | 58 |
|
|
2019
Q4 | $3.74M | Buy |
15,528
+103
| +0.7% | +$22.7K | 0.49% | 60 |
|
|
2019
Q3 | $2.99M | Sell |
15,425
-2,082
| -12% | -$400K | 0.42% | 70 |
|
|
2019
Q2 | $3.23M | Sell |
17,507
-746
| -4% | -$134K | 0.49% | 62 |
|
|
2019
Q1 | $3.47M | Sell |
18,253
-225
| -1% | -$43K | 0.56% | 59 |
|
|
2018
Q4 | $3.6M | Sell |
18,478
-433
| -2% | -$84.5K | 0.66% | 55 |
|
|
2018
Q3 | $3.92M | Sell |
18,911
-993
| -5% | -$196K | 0.62% | 56 |
|
|
2018
Q2 | $3.67M | Buy |
19,904
+219
| +1% | +$38.7K | 0.63% | 54 |
|
|
2018
Q1 | $3.36M | Sell |
19,685
-110
| -0.6% | -$20.2K | 0.6% | 61 |
|
|
2017
Q4 | $3.44M | Buy |
19,795
+264
| +1% | +$46.7K | 0.62% | 62 |
|
|
2017
Q3 | $3.64M | Buy |
19,531
+2
| +0% | +$354 | 0.7% | 58 |
|
|
2017
Q2 | $3.36M | Buy |
19,529
+472
| +2% | +$76.8K | 0.68% | 58 |
|
|
2017
Q1 | $3.13M | Buy |
19,057
+16,245
| +578% | +$2.7M | 0.64% | 56 |
|
|
2016
Q4 | $411K | Hold |
2,812
| – | – | 0.09% | 118 |
|
|
2016
Q3 | $469K | Hold |
2,812
| – | – | 0.1% | 112 |
|
|
2016
Q2 | $428K | Sell |
2,812
-250
| -8% | -$38.9K | 0.1% | 117 |
|
|
2016
Q1 | $459K | Hold |
3,062
| – | – | 0.12% | 113 |
|
|
2015
Q4 | $497K | Buy |
3,062
+88
| +3% | +$13.8K | 0.12% | 117 |
|
|
2015
Q3 | $411K | Buy |
2,974
+71
| +2% | +$11.2K | 0.11% | 120 |
|
|
2015
Q2 | $446K | Hold |
2,903
| – | – | 0.11% | 118 |
|
|
2015
Q1 | $464K | Buy |
2,903
+18
| +0.6% | +$2.83K | 0.12% | 120 |
|
|
2014
Q4 | $460K | Buy |
2,885
+53
| +2% | +$8.26K | 0.12% | 126 |
|
|
2014
Q3 | $398K | Buy |
2,832
+8
| +0.3% | +$1.04K | 0.11% | 140 |
|
|
2014
Q2 | $334K | Buy |
2,824
+14
| +0.5% | +$1.62K | 0.09% | 146 |
|
|
2014
Q1 | $347K | Sell |
2,810
-7
| -0.2% | -$849 | 0.22% | 85 |
|
|
2013
Q4 | $321K | Buy |
2,817
+23
| +0.8% | +$2.62K | 0.21% | 77 |
|
|
2013
Q3 | $313K | Buy |
2,794
+17
| +0.6% | +$1.84K | 0.25% | 62 |
|
|
2013
Q2 | $274K | Buy |
+2,777
| New | +$288K | 0.22% | 72 |
|
Other funds holding AMGN
FFM
SP
Smith Salley Wealth Management's AMGN Position: Q2 2026 in Review
Smith Salley Wealth Management increased its Amgen (AMGN) stake by 1.8% in Q2 2026, buying an estimated $70.2K and bringing the position to 11,307 shares worth $4.09M. The position accounts for 0.18% of the portfolio, ranked #87.
Smith Salley Wealth Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.21M in Q4 2023. 1,292 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Smith Salley Wealth Management held 11,307 shares of Amgen worth $4.09M as of Q2 2026.
- Smith Salley Wealth Management bought 205 Amgen shares in Q2 2026, an estimated $70.2K.
- Amgen made up 0.18% of Smith Salley Wealth Management's portfolio in Q2 2026, its #87 holding.
- Smith Salley Wealth Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- Smith Salley Wealth Management's Amgen position peaked at $5.21M in Q4 2023.
- 1,292 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Smith Salley Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.